Time-dependent observations of secretion marker levels in nasal secretion after histamine and methacholine provocations

Archivum Immunologiae et Therapiae Experimentalis

Volumn 51, Issue 4, 2003, Pages 259-265

  Pupek, Malgorzata ^a   Mikulewicz, Wojciech ^b   Mielnik, Jarosław ^a,b   Batycka, Bozena ^b   Ka̧tnik Prastowska, Iwona ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b Regional Railway Hospital of Wroclaw   (Poland)

Author keywords

IgA; Lactoferrin; Nasal challange; Nasal secretion markers; Secretory IgA

Indexed keywords

ALBUMIN; HISTAMINE; IMMUNOGLOBULIN A; LACTOFERRIN; METHACHOLINE; PLASMA PROTEIN; SECRETORY IMMUNOGLOBULIN; SODIUM CHLORIDE;

ADULT; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOELECTROPHORESIS; INFLAMMATION; MALE; NORMAL HUMAN; NOSE MUCOSA; NOSE SECRETION; PROVOCATION TEST; RHINITIS; TIME;

ADULT; ALBUMINS; BIOLOGICAL MARKERS; HISTAMINE; HUMANS; IMMUNOGLOBULIN A; LACTOFERRIN; MALE; METHACHOLINE CHLORIDE; MUSCARINIC AGONISTS; NASAL LAVAGE FLUID; NASAL MUCOSA; NASAL PROVOCATION TESTS; TIME FACTORS;

EID: 0042426104     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. BAUMGARTEN C. R., SCHMITZ P., O'CONNOR A. and KUNKEL G. (2002): Effects on β-endorphin on nasal allergic inflammation. Clin. Exp. Allergy, 32, 228-236.
2. BROFELDT S., MYGIND N., SØRENSEN C., READMAN A. S. and MARRIOTT C. (1986): Biochemical analysis of nasal secretions induced by methacholine, histamine, and allergen provocations. Am. Rev. Respir. Dis., 133, 1138-1142.
3. CORTHESY B. and SPERTINI F. (1999): Secretory immunoglobulin A: from mucosal protection to vaccine development. Biol. Chem., 380, 1251-1262.
4. DE GRAAF-IN'T VELD C., GARRELDS I. M., VAN TOORENENBERGEN A. W. and GERTH VAN WIJK R. (1997): Nasal responsiveness to allergen and histamine in patients with perennial rhinitis with and without a late phase response. Thorax, 52, 143-148.
5. ECCLES R. (1992): Plasma exudation in rhinitis. Clin. Exp. Allergy, 22, 319-320.
6. GERTH VAN WIJK R. and DIEGES P. H. (1994): Nasal reactivity to histamine and methacholine: two different forms of upper airway responsiveness. Rhinology, 32, 119-122.
7. GOSSET P., TILLIE-LEBLOND I., MALAQUIN F., DURIEU J., WALLAERT B. and TONNEL A.-B. (1997): Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages. Clin. Exp. Allergy, 27, 379-388.
8. KOWALSKI M., ŚLIWIŃSKA-KOWALSKA M., YASUSHI I., MARTHA V. W., WOJCIECHOWSKA B., PHYLIS B., HELEN K., ROZNIECKI J. and KALINER M. A. (1993): Nasal secretion in response to acetylsalicylic acid. J. Allergy Clin. Immunol., 91, 580-598.
9. LORIN M. I., GAERLAN P. F. and MAXDEL I. D. (1972): Quantitative composition of nasal secretions in normal subjects. J. Lab. Clin. Med., 80, 275-280.
10. OHM M. and JUTO J. E. (1993): Nasal hyperreactivity A histamine provocation model. Rhinology, 31, 53-55.
11. PEARS F. L. (1991): Biological effects of histamine: an overview. Agents Actions, 33, 4-7.
12. PIRILÄ T. and NUUTINEN J. (1998): Acoustic rtinometry, rhinomanometry and the amount of nasal secretion in the clinical monitoring of the nasal provocation test. Clin. Exp. Allergy, 28, 468-477.
13. PRIETO L., GUTIERREZ V., MORALES C. and MARIN J. (1998): Differences in sensitivity, maximal response and position of concentration-response curve to methacholine between asthmatic patients with allergic rhinitis and healthy subjects. Respir. Med., 92, 88-94.
14. RAPHAEL G. D., DRUCE H. M., BARANIUK J. N. and KALINER M. A. (1988): Pathophysiology of rhinitis. I. Assessment of the sources of protein in methacholine-induced nasal secretions. Am. Rev. Respir. Dis., 138, 413-420.
15. RAPHAEL G. D., JENEY E. V., BARANIUK J. N., KIM I., MEREDITH S. D. and KALINER M. A. (1989): Lactoferrin and lysozyme in nasal secretions. J. Clin. Invest. Inc., 84, 1528-1535.
16. RAPHAEL G. D., MEREDITH S. D., BARANIUK J. N., DRUCE H. M., BANKS S. M. and KALINER M. A. (1989): Pathophysiology of rhinitis. II. Assessment of the sources of protein in histamine-induced nasal secretions. Am. Rev. Respir. Dis., 139, 791-800.
17. SMITH P. K., KROHN R. I., HERMANSON G. T., MALLIA A. K., GARTNER F. H., PROVENZANO M. D., FUJIMOTO E. K., GOEKE N. M., OLSON B. J. and KLENK D. C. (1985): Measurement of protein using bicichonic acid. Anal. Biochem., 150, 76-85.
18. SANICO A. M., PHILIP G., PROUD D., NACLERIO R. M. and TOUGIAS A. (1998): Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis; effects of capsaicin nasal challenge. Clin. Exp. Allergy, 28, 92-100.
19. SMERALDI A., CRIMI E., MILANESE M., ROSSETTI A., CANTINI L. and BRUSANSCO V. (2002): Efficacy of ipratropium bromide aqueous nasal spray in the prevention of nasal secretion induced by inhaled methacholine. Clin. Drug Invest., 22, 263-268.
20. WEEKE B. (1973): Rocket immunoelectrophoresis. Scand. J. Immunol., 2, 37-46.
21. WILSON S. J., LAU L. and HOWARTH P. H. (1998): Inflammatory mediators in naturally occuring rhinitis. Clin. Exp. Allergy, 28, 220-227.
22. WOJNAROWSKI C., STUDNICKA M., KÜHR J., KOLLER D. Y., HASCHKE N., GARTNER C., REZ S. and FRISCHER T. (1998): Determinants of eosinophil cationic protein in nasal lavages in children. Clin. Exp. Allergy, 28, 300-305.